1 Segni M, Leonardi E, Mazzoncini B, Pucarelli I, Pasquino AM. 1999 Special features of Graves’ disease in early childhood. Thyroid 9:871.
212. Hung W, Wilkins L, Blizzard R: Medical therapy of thyro- toxicosis in children. Pediatrics 30:17, 1962.
213. Starr P, Jaffe HL, Oettinger L Jr: Late results of 131-I treatment of hyperthyroidism in seventy-three children and adosescents. J Nucl Med 5:81, 1964. 213.1. Perrild H, Jacobsen BB. Thyrotoxicosis in childhood. Europ J Endocrinol 134:678-679, 1996.
214. Kogut MD, Kaplan SA, Collipp PJ, Tiamsic T, Boyle D: Treatment of hyperthyroidism in children. N Engl J Med 272:217, 1965.
214.1. Rivkees SA, Sklar C, Freemark M. The management of Gravesâ€™ disease in children, with special emphasis on radioiodine treatment. J Clin Endocrinol Metab 83:3767-3776.
214.11: Read CH Jr, Tansey MJ, Menda Y. A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves’ patients. J Clin Endocrinol Metab. 2004 Sep;89(9):4229-33.
215. Okuno A, Yano K, Inyaku F, Suzuki Y, Sanae N, Kumai M, Naitoh Y. Pharmacokinetics of methimazole in children and adolescents with Gravesâ€™ disease. Acta Endocrinol (Copenh) 115:112-118, 1987.
215.1 Barrio R, Lopez-Capape M, Martinez-Badas I, Carrillo A, Moreno JC, Alonso M.Graves’ disease in children and adolescents: response to long-term treatment.Acta Paediatr. 2005 Nov;94(11):1583-9
215.12 Léger J, Gelwane G, Kaguelidou F, Benmerad M, Alberti C; French Childhood Graves’ Disease Study Group Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves’ disease: national long-term cohort study.J Clin Endocrinol Metab. 2012 Jan;97(1):110-9.
215.2 Koch CA, Sarlis NJ. The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood: Natural history, diagnosis, differential diagnosis and management. J Endocrinol Invest 24:659-675, 2001.
216. Rudberg C, Johansson H, Akerstrom G, Tuvemo T, Karlsson FA. Gravesâ€™ disease in children and adolescents. Late results of surgical treatment. Europ J Endocrinol 134:710-715, 1996.
217. Cheek JH, Rezvani I, Goodner D, Hopper B: Prenatal treatment of thyrotoxicosis to prevent intrauterine growth retardation. Obstet Gynecol 60:122, 1982.
217.1 Clementi M, Di Gianantonio E, Pelo E, Mammi I, Basile RT, Tenconi R. 1999 Methimazole embryopathy: delineation of the phenotype. Amer J Medical Genet. 83:43-46.
217.2 Luton D, Le Gac I, Vuillard E, Castanet M, Guibourdenche J, Noel M, Toubert ME, Leger J, Boissinot C, Schlageter MH, Garel C, Tebeka B, Oury JF, Czernichow P, Polak M.Management of Graves’ disease during pregnancy: the key role of fetal thyroid gland monitoring.J Clin Endocrinol Metab. 2005 Nov;90(11):6093-8
218.1 Zimmerman D. 1999 Fetal and neonatal hyperthyroidism. Thyroid 9:727.
218. Jarett SN, Seniour B, Braudo JL, Heymann S: Neonatal thyrotoxicosis. Pediatrics 24:65, 1959.
219. Hollingsworth DR, Mabry CC, Eckerd JM: Hereditary aspects of Graves’ disease in infancy and childhood. J Pediatr 81:446, 1972.